HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ).

Abstract
Osteonecrosis of the jaw (ONJ), a rare, but potentially severe side effect of anti-resorptive medications, presents as exposed bone in the maxillofacial region lasting for at least 8 weeks. While clinical experience and animal models concur in finding that systemic antiresorptive treatment in conjunction with local risk factors, such as tooth extraction or dental disease may lead to ONJ development, the subclinical molecular changes that precede bone exposure remain poorly understood. The identification of these changes is not only important in understanding disease pathophysiology, but could provide potential for treatment development. Here, we evaluated the early stages of ONJ utilizing a model of experimental periodontitis (EP) in mice treated with two different types of antiresorptives, targeting potential changes in vasculature, hypoxia, oxidative stress, and apoptosis. Antiresorptive treatment in animals with EP increased levels of empty osteocytic lacunae and increased ONJ prevalence compared to Veh animals. The arteriole and venule network seen around EP areas was diminished in animals treated with antiresorptives. Higher levels of vascular endothelial growth factor A (VEGF-A) and vascular cell adhesion protein-1 (VCAM-1) were observed 1-week following EP in treated animals. Finally, levels of hypoxia, oxidative stress, and apoptosis remained high in antiresorptive treated animals with EP through the duration of the experiment. Together, our data point to subclinical vasculature organizational disturbances that subsequently affect levels of hypoxia, oxidative stress, and apoptosis in the area of developing ONJ.
AuthorsIoannis Gkouveris, Danny Hadaya, Akrivoula Soundia, Olga Bezouglaia, Yee Chau, Sarah M Dry, Flavia Q Pirih, Tara L Aghaloo, Sotirios Tetradis
JournalBone (Bone) Vol. 123 Pg. 234-245 (06 2019) ISSN: 1873-2763 [Electronic] United States
PMID30953717 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2019. Published by Elsevier Inc.
Chemical References
  • Vascular Cell Adhesion Molecule-1
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse
Topics
  • Animals
  • Jaw (blood supply, diagnostic imaging, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Osteonecrosis (diagnostic imaging, metabolism)
  • Periodontium (blood supply, diagnostic imaging, metabolism)
  • Random Allocation
  • Vascular Cell Adhesion Molecule-1 (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: